交易 CytomX Therapeutics Inc - CTMX CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
Long position overnight fee
前往平台 | -0.024068% | ||||||||
空頭倉位隔夜費用
Short position overnight fee
前往平台 | 0.001846% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 20% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Jun 29, 2022 | 1.86 | 0.04 | 2.20% | 1.82 | 1.96 | 1.78 |
Jun 28, 2022 | 1.85 | -0.09 | -4.64% | 1.94 | 1.94 | 1.80 |
Jun 27, 2022 | 1.92 | 0.04 | 2.13% | 1.88 | 1.97 | 1.83 |
Jun 24, 2022 | 1.87 | -0.05 | -2.60% | 1.92 | 1.97 | 1.83 |
Jun 23, 2022 | 1.84 | 0.14 | 8.24% | 1.70 | 1.85 | 1.70 |
Jun 22, 2022 | 1.77 | 0.12 | 7.27% | 1.65 | 1.81 | 1.62 |
Jun 21, 2022 | 1.68 | 0.06 | 3.70% | 1.62 | 1.71 | 1.58 |
Jun 17, 2022 | 1.58 | -0.03 | -1.86% | 1.61 | 1.70 | 1.57 |
Jun 16, 2022 | 1.63 | -0.04 | -2.40% | 1.67 | 1.67 | 1.57 |
Jun 15, 2022 | 1.70 | 0.07 | 4.29% | 1.63 | 1.73 | 1.61 |
Jun 14, 2022 | 1.65 | -0.05 | -2.94% | 1.70 | 1.72 | 1.64 |
Jun 13, 2022 | 1.71 | -0.03 | -1.72% | 1.74 | 1.76 | 1.68 |
Jun 10, 2022 | 1.83 | -0.02 | -1.08% | 1.85 | 1.85 | 1.77 |
Jun 9, 2022 | 1.92 | 0.07 | 3.78% | 1.85 | 1.93 | 1.81 |
Jun 8, 2022 | 1.88 | 0.02 | 1.08% | 1.86 | 1.98 | 1.86 |
Jun 7, 2022 | 1.86 | 0.16 | 9.41% | 1.70 | 1.91 | 1.67 |
Jun 6, 2022 | 1.71 | -0.06 | -3.39% | 1.77 | 1.83 | 1.71 |
Jun 3, 2022 | 1.76 | 0.22 | 14.29% | 1.54 | 1.78 | 1.54 |
Jun 2, 2022 | 1.58 | 0.06 | 3.95% | 1.52 | 1.59 | 1.49 |
Jun 1, 2022 | 1.53 | -0.05 | -3.16% | 1.58 | 1.67 | 1.50 |
CytomX Therapeutics Inc Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
總收入 | 69.573 | 100.362 | 57.489 | 59.502 | 71.623 |
收入 | 69.573 | 100.362 | 57.489 | 59.502 | 71.623 |
總營業費用 | 153.354 | 148.967 | 168.384 | 137.376 | 117.882 |
銷售/一般/行政費用,總計 | 39.16 | 36.031 | 36.765 | 33.51 | 25.605 |
研究與開發 | 114.194 | 112.936 | 131.619 | 103.866 | 92.277 |
營業收入 | -83.781 | -48.605 | -110.895 | -77.874 | -46.259 |
利息收入(費用),非經營淨值 | 0.255 | 1.836 | 8.365 | 7.641 | 2.674 |
其他,淨值 | -0.083 | -0.027 | -0.135 | -0.068 | -0.027 |
稅前淨收入 | -83.609 | -46.796 | -102.665 | -70.301 | -43.612 |
稅後淨收入 | -83.609 | -32.885 | -102.238 | -84.604 | -68.799 |
未計算非常項目前的淨收益 | -83.609 | -32.885 | -102.238 | -84.604 | -68.799 |
淨收入 | -83.609 | -32.885 | -102.238 | -84.604 | -43.099 |
Total Adjustments to Net Income | 0 | ||||
普通股股東可獲收益 (不含非經常性項目) | -83.609 | -32.885 | -102.238 | -84.604 | -68.799 |
普通股股東可獲收益 (含非經常性項目) | -83.609 | -32.885 | -102.238 | -84.604 | -43.099 |
攤薄淨收入 | -83.609 | -32.885 | -102.238 | -84.604 | -43.099 |
攤薄後加權平均股 | 64.1469 | 46.1456 | 45.3359 | 41.6644 | 37.1668 |
扣除特別項目的每股攤薄盈利 | -1.3034 | -0.71264 | -2.25512 | -2.03061 | -1.85109 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -1.3034 | -0.71264 | -2.25512 | -2.03061 | -1.85109 |
非常規項目總計 | 25.7 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
總收入 | 17.136 | 19.727 | 17.587 | 16.288 | 15.971 |
收入 | 17.136 | 19.727 | 17.587 | 16.288 | 15.971 |
總營業費用 | 41.102 | 46.035 | 40.228 | 35.493 | 31.598 |
銷售/一般/行政費用,總計 | 10.543 | 9.456 | 11.085 | 9.393 | 9.227 |
研究與開發 | 30.559 | 36.579 | 29.143 | 26.1 | 22.371 |
營業收入 | -23.966 | -26.308 | -22.641 | -19.205 | -15.627 |
利息收入(費用),非經營淨值 | 0.068 | 0.073 | 0.07 | 0.044 | 0.068 |
其他,淨值 | 0.013 | 0.007 | -0.013 | -0.082 | 0.005 |
稅前淨收入 | -23.885 | -26.228 | -22.584 | -19.243 | -15.554 |
稅後淨收入 | -23.885 | -26.228 | -22.584 | -19.243 | -15.554 |
未計算非常項目前的淨收益 | -23.885 | -26.228 | -22.584 | -19.243 | -15.554 |
淨收入 | -23.885 | -26.228 | -22.584 | -19.243 | -15.554 |
普通股股東可獲收益 (不含非經常性項目) | -23.885 | -26.228 | -22.584 | -19.243 | -15.554 |
普通股股東可獲收益 (含非經常性項目) | -23.885 | -26.228 | -22.584 | -19.243 | -15.554 |
攤薄淨收入 | -23.885 | -26.228 | -22.584 | -19.243 | -15.554 |
攤薄後加權平均股 | 65.3937 | 65.3086 | 65.2081 | 65.056 | 60.9681 |
扣除特別項目的每股攤薄盈利 | -0.36525 | -0.4016 | -0.34634 | -0.29579 | -0.25512 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.36525 | -0.4016 | -0.34634 | -0.29579 | -0.25512 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
流動資産總額 | 310.301 | 324.013 | 303.335 | 445.475 | 388.601 |
現金和短期投資 | 305.226 | 316.119 | 296.145 | 436.127 | 374.11 |
現金等價物 | 205.53 | 191.859 | 188.425 | 247.577 | 177.548 |
短期投資 | 99.696 | 124.26 | 107.72 | 188.55 | 196.562 |
應收賬款總額,淨額 | 0.79 | 0.798 | 0.013 | 0.097 | 10.139 |
Accounts Receivable - Trade, Net | 0.79 | 0.798 | 0.013 | 0.097 | 10.139 |
Prepaid Expenses | 4.285 | 7.096 | 7.177 | 9.251 | 4.352 |
Total Assets | 339.411 | 358.663 | 341.282 | 457.108 | 397.644 |
Property/Plant/Equipment, Total - Net | 25.322 | 29.445 | 32.754 | 6.934 | 4.218 |
Property/Plant/Equipment, Total - Gross | 39.154 | 40.871 | 41.804 | 13.88 | 9.426 |
Accumulated Depreciation, Total | -13.832 | -11.426 | -9.05 | -6.946 | -5.208 |
Goodwill, Net | 0.949 | 0.949 | 0.949 | 0.949 | 0.949 |
Intangibles, Net | 1.021 | 1.167 | 1.312 | 1.458 | 1.604 |
Other Long Term Assets, Total | 1.818 | 3.089 | 2.932 | 2.292 | 2.272 |
Total Current Liabilities | 106.316 | 100.924 | 85.59 | 97.908 | 61.147 |
Accounts Payable | 2.818 | 2.996 | 4.158 | 5.132 | 4.205 |
Accrued Expenses | 34.236 | 23.059 | 30.051 | 26.724 | 16.383 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 69.262 | 74.869 | 51.381 | 66.052 | 40.559 |
Total Liabilities | 250.032 | 308.86 | 290.169 | 326.225 | 327.748 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Deferred Income Tax | |||||
Other Liabilities, Total | 143.716 | 207.936 | 204.579 | 228.317 | 266.601 |
Total Equity | 89.379 | 49.803 | 51.113 | 130.883 | 69.896 |
Common Stock | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
Additional Paid-In Capital | 623.344 | 499.964 | 468.285 | 445.956 | 289.454 |
Retained Earnings (Accumulated Deficit) | -533.724 | -450.115 | -417.23 | -314.981 | -219.465 |
Other Equity, Total | -0.242 | -0.047 | 0.057 | -0.093 | -0.094 |
Total Liabilities & Shareholders’ Equity | 339.411 | 358.663 | 341.282 | 457.108 | 397.644 |
Total Common Shares Outstanding | 65.3928 | 48.2518 | 45.5231 | 45.0832 | 38.4786 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流動資産總額 | 268.444 | 310.301 | 240.998 | 271.005 | 400.008 |
現金和短期投資 | 262.53 | 305.226 | 236.289 | 266.177 | 393.796 |
現金等價物 | 163.488 | 205.53 | 236.284 | 256.146 | 329.666 |
短期投資 | 99.042 | 99.696 | 0.005 | 10.031 | 64.13 |
應收賬款總額,淨額 | 1.016 | 0.79 | 0.887 | 0.931 | 0.756 |
Accounts Receivable - Trade, Net | 1.016 | 0.79 | 0.887 | 0.931 | 0.756 |
Prepaid Expenses | 4.898 | 4.285 | 3.822 | 3.897 | 5.456 |
Total Assets | 296.825 | 339.411 | 371.233 | 402.44 | 434.158 |
Property/Plant/Equipment, Total - Net | 24.629 | 25.322 | 26.441 | 27.66 | 28.908 |
Goodwill, Net | 0.949 | 0.949 | 0.949 | 0.949 | 0.949 |
Intangibles, Net | 0.984 | 1.021 | 1.057 | 1.094 | 1.13 |
Other Long Term Assets, Total | 1.819 | 1.818 | 1.819 | 1.818 | 3.163 |
Total Current Liabilities | 102.766 | 106.316 | 99.772 | 93.377 | 98.049 |
Accounts Payable | 1.721 | 2.818 | 1.516 | 1.755 | 2.582 |
Accrued Expenses | 31.032 | 34.236 | 25.167 | 19.253 | 18.831 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 70.013 | 69.262 | 73.089 | 72.369 | 76.636 |
Total Liabilities | 228.631 | 250.032 | 259.559 | 271.487 | 288.136 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 125.865 | 143.716 | 159.787 | 178.11 | 190.087 |
Total Equity | 68.194 | 89.379 | 111.674 | 130.953 | 146.022 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | |||
Common Stock | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 |
Additional Paid-In Capital | 626.721 | 623.344 | 619.117 | 615.849 | 611.733 |
Retained Earnings (Accumulated Deficit) | -557.609 | -533.724 | -507.496 | -484.912 | -465.669 |
Other Equity, Total | -0.919 | -0.242 | 0.052 | 0.015 | -0.043 |
Total Liabilities & Shareholders’ Equity | 296.825 | 339.411 | 371.233 | 402.44 | 434.158 |
Total Common Shares Outstanding | 65.3984 | 65.3928 | 65.2491 | 65.157 | 65.0029 |
Long Term Investments | 99.969 | 99.914 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
淨收入/起跑線 | -83.609 | -32.885 | -102.238 | -84.604 | -43.099 |
經營活動産生的現金 | -119.031 | 5.259 | -140.48 | -75.521 | 170.373 |
經營活動産生的現金 | 2.56 | 2.427 | 2.459 | 1.884 | 1.645 |
Deferred Taxes | -0.513 | ||||
非現金物品 | 16.572 | 17.437 | 18.474 | 15.177 | 22.375 |
營運資金的變化 | -54.7 | 18.134 | -59.321 | -7.978 | 189.965 |
投資活動産生的現金 | 22.489 | -18.718 | 79.701 | 5.926 | -121.266 |
資本支出 | -1.609 | -2.309 | -3.497 | -3.788 | -1.559 |
其他投資現金流量項目,總計 | 24.098 | -16.409 | 83.198 | 9.714 | -119.707 |
融資活動産生的現金 | 110.213 | 16.893 | 1.627 | 139.624 | 23.796 |
融資現金流項目 | 0 | 0 | |||
股票的發行(報廢),淨額 | 110.213 | 16.893 | 1.627 | 139.624 | 23.796 |
債務的發行(退還),淨額 | 0 | ||||
現金淨變化 | 13.671 | 3.434 | -59.152 | 70.029 | 72.903 |
Amortization | 0.146 | 0.146 | 0.146 | ||
Cash Taxes Paid | 0 | 0 | 13.061 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -23.885 | -83.609 | -57.381 | -34.797 | -15.554 |
Cash From Operating Activities | -41.313 | -119.031 | -87.839 | -58.139 | -29.94 |
Cash From Operating Activities | 0.565 | 2.56 | 1.921 | 1.278 | 0.638 |
Amortization | 0.037 | 0.146 | 0.11 | 0.073 | 0.036 |
Non-Cash Items | 4.179 | 16.572 | 12.235 | 8.274 | 3.934 |
Changes in Working Capital | -22.209 | -54.7 | -44.724 | -32.967 | -18.994 |
Cash From Investing Activities | -0.736 | 22.489 | 22.734 | 13 | 59.012 |
Capital Expenditures | -0.736 | -1.609 | -1.364 | -1.096 | -0.982 |
Other Investing Cash Flow Items, Total | 0 | 24.098 | 24.098 | 14.096 | 59.994 |
Cash From Financing Activities | 0.007 | 110.213 | 109.53 | 109.426 | 108.735 |
Issuance (Retirement) of Stock, Net | 0.007 | 110.213 | 109.53 | 109.426 | 108.735 |
Net Change in Cash | -42.042 | 13.671 | 44.425 | 64.287 | 137.807 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
BVF Partners L.P. | Hedge Fund | 9.9809 | 6595801 | 0 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 6.9392 | 4585721 | 47760 | 2022-12-31 | LOW |
Tang Capital Management, LLC | Hedge Fund | 5.3121 | 3510445 | 10445 | 2022-12-31 | MED |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 4.0154 | 2653576 | 0 | 2022-12-31 | MED |
Rubric Capital Management LP | Hedge Fund | 3.6415 | 2406449 | 0 | 2022-12-31 | MED |
Millennium Management LLC | Hedge Fund | 2.6024 | 1719811 | 1187298 | 2022-12-31 | HIGH |
Medical Strategy GmbH | Investment Advisor | 2.5583 | 1690646 | 0 | 2022-09-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 2.0289 | 1340774 | -464826 | 2022-12-31 | HIGH |
Two Sigma Investments, LP | Hedge Fund | 1.9581 | 1293989 | 408628 | 2022-12-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.9432 | 1284168 | -468950 | 2022-12-31 | LOW |
Laurion Capital Management LP | Hedge Fund | 1.9231 | 1270900 | 0 | 2022-12-31 | HIGH |
Assenagon Asset Management S.A. | Investment Advisor | 1.3844 | 914900 | -150492 | 2022-12-31 | HIGH |
Fidelity Management & Research Company LLC | Investment Advisor | 1.0582 | 699283 | 15074 | 2022-12-31 | LOW |
Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 1.045 | 690609 | -438449 | 2022-12-31 | MED |
Platinum Asset Management | Investment Advisor/Hedge Fund | 0.9621 | 635798 | -593747 | 2022-12-31 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 0.9357 | 618374 | 128744 | 2022-12-31 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.9126 | 603075 | 15624 | 2022-12-31 | LOW |
Newtyn Management, LLC | Hedge Fund | 0.8625 | 570000 | -230000 | 2022-12-31 | MED |
Oasis Management Company Ltd. | Investment Advisor/Hedge Fund | 0.818 | 540541 | 0 | 2022-12-31 | LOW |
Gluck (Frederick W) | Individual Investor | 0.8021 | 530069 | 0 | 2022-04-18 | LOW |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Bio Therapeutic Drugs |
650 Gateway Blvd.
Suite 125
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 500.000 多名交易者,選擇與 Capital.com 交易